GW Pharmaceuticals Initiates Phase 3 Pivotal Study in Tuberous Sclerosis Complex

LONDON, April 11, 2016 -- (Healthcare Sales & Marketing Network) -- GW Pharmaceuticals plc (GWPH) (GWP.L) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary ca... Biopharmaceuticals, NeurologyGW Pharmaceuticals, Epidiolex, cannabidiol, Tuberous Sclerosis Complex
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news